Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Digi International
DGII
$2.88B
| $24.9M | ﹤0.01% |
332,090
+43,151
| +15% | +$2.68M |
|
2902
DXC Technology
DXC
$1.79B
| $24.8M | ﹤0.01% |
2,800,420
-1,113,069
| -28% | -$11.5M |
|
2903
Mineralys Therapeutics
MLYS
$2.26B
| $24.7M | ﹤0.01% |
917,213
+68,029
| +8% | +$1.87M |
|
2904
Denali Therapeutics
DNLI
$3.84B
| $24.7M | ﹤0.01% |
961,050
-143,707
| -13% | -$2.95M |
|
2905
Intercorp Financial Services
IFS
$6.03B
| $24.7M | ﹤0.01% |
433,042
-106,003
| -20% | -$5.25M |
|
|
JBS
2906
JBS N.V.
JBS
$44.7B
| $24.7M | ﹤0.01% |
2,081,311
-1,526,397
| -42% | -$22.3M |
|
2907
Allient
ALNT
$1.58B
| $24.6M | ﹤0.01% |
239,309
+87,975
| +58% | +$6.79M |
|
2908
Mach Natural Resources
MNR
$2.09B
| $24.6M | ﹤0.01% |
1,944,485
+762,157
| +64% | +$10.2M |
|
2909
WIX.com
WIX
$3.67B
| $24.6M | ﹤0.01% |
541,226
+149,473
| +38% | +$9.24M |
|
2910
Ultrapar
UGP
$6.87B
| $24.5M | ﹤0.01% |
4,888,789
+21,388
| +0.4% | +$118K |
|
2911
Arcus Biosciences
RCUS
$3.72B
| $24.5M | ﹤0.01% |
795,912
-317,614
| -29% | -$7.85M |
|
2912
Xenon Pharmaceuticals
XENE
$5.81B
| $24.5M | ﹤0.01% |
406,257
-67,502
| -14% | -$3.75M |
|
2913
Monro
MNRO
$405M
| $24.5M | ﹤0.01% |
1,433,169
-49,051
| -3% | -$803K |
|
2914
Tronox
TROX
$862M
| $24.5M | ﹤0.01% |
3,890,180
+516,503
| +15% | +$4.38M |
|
2915
Seacoast Banking Corp of Florida
SBCF
$3.33B
| $24.4M | ﹤0.01% |
735,047
+33,158
| +5% | +$1.03M |
|
|
CHYM
2916
Chime Financial
CHYM
$12.6B
| $24.4M | ﹤0.01% |
1,191,115
+517,065
| +77% | +$10M |
|
2917
Travere Therapeutics
TVTX
$6.19B
| $24.4M | ﹤0.01% |
429,253
+127,598
| +42% | +$5.66M |
|
2918
FMC
FMC
$1.42B
| $24.4M | ﹤0.01% |
2,120,151
-1,279,650
| -38% | -$17.9M |
|
2919
Universal Insurance Holdings
UVE
$1.21B
| $24.4M | ﹤0.01% |
589,139
-13,818
| -2% | -$521K |
|
2920
ProShares Short QQQ
PSQ
$598M
| $24.4M | ﹤0.01% |
972,261
-3,838,979
| -80% | -$104M |
|
2921
BlackRock Core Bond Trust
BHK
$655M
| $24.3M | ﹤0.01% |
2,655,380
-80,051
| -3% | -$727K |
|
2922
Ingevity
NGVT
$2.39B
| $24.3M | ﹤0.01% |
325,811
+52,058
| +19% | +$3.75M |
|
2923
Invesco Municipal Trust
VKQ
$541M
| $24.3M | ﹤0.01% |
2,417,581
+528,053
| +28% | +$5.14M |
|
2924
Fidelity MSCI Consumer Discretionary Index ETF
FDIS
$1.7B
| $24.3M | ﹤0.01% |
235,989
-11,980
| -5% | -$1.21M |
|
2925
BILL Holdings
BILL
$5.01B
| $24.3M | ﹤0.01% |
670,816
+16,879
| +3% | +$622K |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.